Orchestra BioMed Holdings, Inc. Operating Leases, Rent Expense
Orchestra BioMed Holdings, Inc. (OBIO) reported Operating Leases, Rent Expense of $835.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2024-03-27
- Orchestra BioMed Holdings, Inc. operating leases, rent expense for the quarter ending 2023-12-31 was $209.00K, a 14.21% increase year-over-year.
- Orchestra BioMed Holdings, Inc. operating leases, rent expense for the quarter ending 2023-09-30 was $209.00K, a 5.56% increase year-over-year.
- Orchestra BioMed Holdings, Inc. operating leases, rent expense for the quarter ending 2023-06-30 was $209.00K, a 16.11% increase year-over-year.
- Orchestra BioMed Holdings, Inc. operating leases, rent expense for the quarter ending 2023-03-31 was $209.00K, a 20.11% increase year-over-year.
- Orchestra BioMed Holdings, Inc. operating leases, rent expense for fiscal 2023 was $835.00K, a 13.61% increase from fiscal 2022.
- Orchestra BioMed Holdings, Inc. operating leases, rent expense for fiscal 2022 was $735.00K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $418.00K derived: sum of 2 quarters · filed 2024-03-27 | $627.00K derived: sum of 3 quarters · filed 2024-03-27 | $835.00K 10-K · filed 2024-03-27 |
| 2023-09-30 | $209.00K 10-Q · filed 2023-11-13 | $418.00K derived: sum of 2 quarters · filed 2023-11-13 | $626.00K 10-Q · filed 2023-11-13 | $810.00K derived: sum of 4 quarters · filed 2024-03-27 |
| 2023-06-30 | $209.00K 10-Q · filed 2023-08-10 | $417.00K 10-Q · filed 2023-08-10 | $601.00K derived: sum of 3 quarters · filed 2024-03-27 | $799.00K derived: sum of 4 quarters · filed 2024-03-27 |
| 2023-03-31 | $209.00K 10-Q · filed 2023-05-12 | $392.00K derived: sum of 2 quarters · filed 2024-03-27 | $590.00K derived: sum of 3 quarters · filed 2024-03-27 | $770.00K derived: sum of 4 quarters · filed 2024-03-27 |
| 2022-12-31 | $183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $381.00K derived: sum of 2 quarters · filed 2024-03-27 | $561.00K derived: sum of 3 quarters · filed 2024-03-27 | $735.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $198.00K 10-Q · filed 2023-11-13 | $378.00K derived: sum of 2 quarters · filed 2023-11-13 | $552.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $180.00K 10-Q · filed 2023-08-10 | $354.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $174.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |